Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Janneke Wilschut"'
Autor:
Monique E. van Leerdam, Janneke Wilschut, Iris Lansdorp-Vogelaar, J. Dik F. Habbema, Marjolein van Ballegooijen, Ewout W. Steyerberg
Publikováno v:
Cancer, 117(18), 4166-74. John Wiley and Sons Inc.
Wilschut, J A, Steyerberg, E W, van Leerdam, M E, Lansdorp-Vogelaar, I, Habbema, J D F & van Ballegooijen, M 2011, ' How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? ', Cancer, vol. 117, no. 18, pp. 4166-74 . https://doi.org/10.1002/cncr.26009
Cancer, 117(18), 4166-4174. John Wiley & Sons Inc.
Wilschut, J A, Steyerberg, E W, van Leerdam, M E, Lansdorp-Vogelaar, I, Habbema, J D F & van Ballegooijen, M 2011, ' How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? ', Cancer, vol. 117, no. 18, pp. 4166-74 . https://doi.org/10.1002/cncr.26009
Cancer, 117(18), 4166-4174. John Wiley & Sons Inc.
BACKGROUND: Individuals with a family history of colorectal cancer (CRC) are at increased risk for CRC. Current screening recommendations for these individuals are based on expert opinion. The authors investigated optimal screening strategies for ind
Autor:
Rob J. de Boer, Janneke Wilschut, Ann G. Zauber, J. Dik F. Habbema, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen
Publikováno v:
International Journal of Cancer, 124(5), 1161-1168. Wiley-Liss Inc.
The costs of computed tomographic colonography (CTC) are not yet established for screening use. In our study, we estimated the threshold costs for which CTC screening would be a cost-effective alternative to colonoscopy for colorectal cancer (CRC) sc
Autor:
Janneke Wilschut, J. Dik F. Habbema, Lieke Hol, Monique E. van Leerdam, Ernst J. Kuipers, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen
Publikováno v:
Journal of the National Cancer Institute, 103(23), 1741-51. Oxford University Press
Wilschut, J A, Habbema, J D F, van Leerdam, M E, Hol, L, Lansdorp-Vogelaar, I, Kuipers, E J & van Ballegooijen, M 2011, ' Fecal occult blood testing when colonoscopy capacity is limited ', Journal of the National Cancer Institute, vol. 103, no. 23, pp. 1741-51 . https://doi.org/10.1093/jnci/djr385
Journal of the National Cancer Institute, 103(23), 1741-1751. Oxford University Press
Wilschut, J A, Habbema, J D F, van Leerdam, M E, Hol, L, Lansdorp-Vogelaar, I, Kuipers, E J & van Ballegooijen, M 2011, ' Fecal occult blood testing when colonoscopy capacity is limited ', Journal of the National Cancer Institute, vol. 103, no. 23, pp. 1741-51 . https://doi.org/10.1093/jnci/djr385
Journal of the National Cancer Institute, 103(23), 1741-1751. Oxford University Press
BACKGROUND: Fecal occult blood testing (FOBT) can be adapted to a limited colonoscopy capacity by narrowing the age range or extending the screening interval, by using a more specific test or hemoglobin cutoff level for referral to colonoscopy, and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b072b47b718f65134d4b5b65c63a13
https://research.vumc.nl/en/publications/38362bcc-520a-4a6e-9417-007ee9414d7c
https://research.vumc.nl/en/publications/38362bcc-520a-4a6e-9417-007ee9414d7c
Autor:
J. Dik F. Habbema, Caspar W. N. Looman, Scott D. Ramsey, Marjolein van Ballegooijen, Rob J. de Boer, Janneke Wilschut
Publikováno v:
Wilschut, J A, Habbema, J D F, Ramsey, S D, Boer, R, Looman, C W N & van Ballegooijen, M 2010, ' Increased risk of adenomas in individuals with a family history of colorectal cancer : results of a meta-analysis ', CCC. Cancer Causes and Control, vol. 21, no. 12, pp. 2287-93 . https://doi.org/10.1007/s10552-010-9654-y
Cancer Causes & Control, 21(12), 2287-2293. Springer Netherlands
Cancer Causes & Control, 21(12), 2287-2293. Springer Netherlands
OBJECTIVE: It is unclear to what extent the increased risk of colorectal cancer in individuals with a family history of colorectal cancer and no known genetic disorders is associated with a higher adenoma prevalence. Our aim is to estimate the relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21cadd471858877fd8ffc847fa152eb
https://research.vumc.nl/en/publications/0c15baa5-b157-42f0-ba26-20412fbb6552
https://research.vumc.nl/en/publications/0c15baa5-b157-42f0-ba26-20412fbb6552
Autor:
A C M van der Togt, Janneke Wilschut, Jacqueline C. Reijerink, A J van Vuuren, H van der Valk, M. van Ballegooijen, E. J. Kuipers, Lieke Hol, J. D. F. Habbema, M E van Leerdam
Publikováno v:
British Journal of Cancer
Hol, L, Wilschut, J A, van Ballegooijen, M, van Vuuren, A J, van der Valk, H, Reijerink, J C I Y, van der Togt, A C M, Kuipers, E J, Habbema, J D F & van Leerdam, M E 2009, ' Screening for colorectal cancer : random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels ', British Journal of Cancer, vol. 100, no. 7, pp. 1103-10 . https://doi.org/10.1038/sj.bjc.6604961
British Journal of Cancer, 100(7), 1103-10. Nature Publishing Group
British Journal of Cancer, 100(7), 1103-1110. Nature Publishing Group
Hol, L, Wilschut, J A, van Ballegooijen, M, van Vuuren, A J, van der Valk, H, Reijerink, J C I Y, van der Togt, A C M, Kuipers, E J, Habbema, J D F & van Leerdam, M E 2009, ' Screening for colorectal cancer : random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels ', British Journal of Cancer, vol. 100, no. 7, pp. 1103-10 . https://doi.org/10.1038/sj.bjc.6604961
British Journal of Cancer, 100(7), 1103-10. Nature Publishing Group
British Journal of Cancer, 100(7), 1103-1110. Nature Publishing Group
Immunochemical faecal occult blood testing (FIT) provides quantitative test results, which allows optimisation of the cut-off value for follow-up colonoscopy. We conducted a randomised population-based trial to determine test characteristics of FIT (
Autor:
Rob J. de Boer, J. Dik F. Habbema, Ann G. Zauber, Janneke Wilschut, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar
Publikováno v:
International Journal of Cancer. 125:1239-1240